PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
January 1, 2004Circulation Journal169 citationsOpen Access

Progressive Nature of Paroxysmal Atrial Fibrillation-Observations From a 14-Year Follow-up Study-

TKTakeshi KatoTYTakeshi YamashitaKSKouichi Sagara

Key Result

Paroxysmal atrial fibrillation progressed to chronic AF in 77.2% of patients over 14.1 years, with aging, dilated left atrium, myocardial infarction, and valvular disease as independent predictors.

Study Design

Type

Cohort (n=171)

Structured PICO

What is the long-term clinical course and rate of progression from paroxysmal to chronic atrial fibrillation?

P
Population
171 patients with recurrent paroxysmal atrial fibrillation (PAF) from its onset, mean age 58.3 years, 73.1% male. Included patients with no structural heart disease (n=88), ischemic heart disease (n=28), dilated or hypertrophic cardiomyopathy (n=17), valvular heart disease (n=35), or other cardiac diseases.
I
Intervention
Conventional antiarrhythmic therapy (predominantly Vaughan Williams class 1 drugs) and rate control as determined by attending physicians.
O
Outcome
Development of chronic AF (defined as unsuccessful defibrillation or continuous AF for more than 6 months)hard clinical

Paroxysmal atrial fibrillation is a progressive disease that eventually develops into chronic AF in the majority of patients over long-term follow-up, especially in those with structural heart disease or left atrial enlargement.

Limitations

  • Retrospective design
  • Japanese population only (cannot extrapolate to other ethnic groups)
  • Potential bias due to loss to follow-up of severe stroke patients
  • Class 3 antiarrhythmic drugs were not generally used

Abstract

BACKGROUND: Atrial fibrillation (AF) is believed to occur first as paroxysmal, then be gradually perpetuated, and finally become chronic as the end result. However, this presumed clinical course has not been well confirmed. METHODS AND RESULTS: The clinical course of recurrent paroxysmal AF (PAF) from its onset was examined in 171 patients (mean follow-up period: 14.1+/-8.1 years). This study population consisted of patients with no structural heart disease (n=88), ischemic heart disease (n=28), dilated or hypertrophic cardiomyopathy (n=17), valvular heart disease (n=35) or other cardiac diseases. The mean age at the onset of AF was 58.3 +/-11.8 years old. During the mean follow-up period of 14.1 years, PAF eventually developed into its chronic form in 132 patients under conventional antiarrhythmic therapy (77.2%, 5.5% of patients per year). The independent factors for early development into chronic AF were aging (hazard ratio (HR) 1.27 per 10 years, 95% confidence interval (CI) 1.06-1.47)), dilated left atrium (HR 1.39 per 10 mm, 95% CI 1.11-1.69), myocardial infarction (HR 2.33, 95% CI 1.13-4.81), and valvular diseases (HR 2.29, 95% CI 1.22-4.30). CONCLUSIONS: The present long-term observations definitely and quantitatively revealed the progressive nature of PAF.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Kato et al. (2004) conducted a cohort in Paroxysmal Atrial Fibrillation (n=171). Conventional antiarrhythmic therapy was evaluated on Development into chronic atrial fibrillation. Paroxysmal atrial fibrillation progressed to chronic AF in 77.2% of patients over 14.1 years, with aging, dilated left atrium, myocardial infarction, and valvular disease as independent predictors.

synapsesocial.com/papers/6a124c5a1d9aa3bb4e343754https://doi.org/10.1253/circj.68.568
Ask AI
Helpful
Bookmark
Share
View Full Paper